News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
65,685 Results
Type
Article (6779)
Company Profile (19)
Press Release (58887)
Section
Business (17000)
Career Advice (83)
Deals (2789)
Drug Delivery (10)
Drug Development (14859)
Employer Resources (16)
FDA (2010)
Job Trends (2402)
News (35800)
Policy (5342)
Tag
Academia (399)
Alliances (5564)
Alzheimer's disease (160)
Approvals (2011)
Bankruptcy (26)
Best Places to Work (2195)
Biotechnology (10)
Breast cancer (11)
Cancer (126)
Career advice (80)
Cell therapy (30)
Clinical research (10448)
Collaboration (46)
COVID-19 (2029)
C-suite (13)
Cystic fibrosis (9)
Data (158)
Diagnostics (398)
Earnings (5716)
Employer resources (15)
Events (8164)
Executive appointments (22)
FDA (2094)
Funding (31)
Gene editing (9)
Gene therapy (24)
GLP-1 (72)
Government (1822)
Healthcare (2229)
Immunology and inflammation (9)
Infectious disease (2091)
Inflammatory bowel disease (24)
Influenza (22)
IPO (1194)
Job creations (320)
Job search strategy (75)
Layoffs (72)
Legal (526)
Lung cancer (13)
Management (10)
Manufacturing (27)
Medical device (435)
Medtech (435)
Mergers & acquisitions (1603)
Metabolic disorders (23)
Multiple sclerosis (10)
Neuroscience (185)
NextGen Class of 2024 (413)
Non-profit (362)
Northern California (129)
Obesity (14)
Opinion (35)
Ovarian cancer (10)
Patents (18)
People (4679)
Phase I (3754)
Phase II (4520)
Phase III (3651)
Pipeline (58)
Postmarket research (425)
Preclinical (1613)
Press Release (20)
Radiopharmaceuticals (14)
Rare diseases (20)
Real estate (510)
Regulatory (3376)
Reports (11)
Research institute (411)
RSV (34)
Southern California (96)
Startups (323)
United States (1368)
Vaccines (640)
Weight loss (15)
Date
Today (38)
Last 7 days (117)
Last 30 days (353)
Last 365 days (3977)
2024 (3480)
2023 (4541)
2022 (7866)
2021 (8864)
2020 (7241)
2019 (3443)
2018 (2591)
2017 (2680)
2016 (2544)
2015 (3091)
2014 (2271)
2013 (1806)
2012 (2044)
2011 (2220)
2010 (2018)
Location
Africa (170)
Alabama (9)
Asia (4488)
Australia (714)
California (241)
Canada (127)
China (20)
Connecticut (12)
Delaware (11)
Europe (11038)
Florida (32)
Georgia (16)
Illinois (14)
Indiana (23)
Maryland (212)
Massachusetts (232)
Minnesota (10)
New Jersey (197)
New York (105)
North Carolina (56)
Northern California (129)
Pennsylvania (105)
South America (112)
Southern California (96)
Texas (25)
Washington State (29)
65,685 Results for "rational vaccines".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Rational Vaccines and Shenzhen Mellow Hope Pharm Industrial Co., Ltd. Announce Collaboration to Develop Herpes Vaccines in China
Rational Vaccines and Shenzhen Mellow Hope Pharm Industrial Co., Ltd. announced they have reached an agreement to jointly develop, manufacture, and commercialize live vaccines against herpes simplex viruses.
October 30, 2023
·
2 min read
Earnings
Moderna Gets Better-Than-Expected Q3 COVID-19 Vaccine Sales, but RSV Shot Disappoints
While Moderna’s Spikevax beat Wall Street estimates in the third quarter, William Blair analyst Myles Minter in a Thursday note to investors said sales of the company’s respiratory syncytial virus vaccine mRESVIA was significantly lower than expected.
November 7, 2024
·
3 min read
·
Tristan Manalac
Vaccines
CDC Reaffirm RSV Vaccination Guidelines, Declines Expanding Coverage to Younger Adults
The CDC’s vaccine advisors on Thursday maintained that respiratory syncytial virus immunization is only recommended for adults aged 75 and older, and in seniors 60 to 74 years who are at risk of severe disease.
October 25, 2024
·
2 min read
·
Tristan Manalac
Patents
GSK Sues Moderna for Alleged Patent Infringement on COVID-19, RSV Vaccines
The lawsuits claim that Moderna used and profited from crucial mRNA technology in its COVID-19 vaccine Spikevax and respiratory syncytial virus shot mResvia.
October 16, 2024
·
2 min read
·
Tristan Manalac
Vaccines
5 Late-Stage mRNA Vaccines to Watch
The potential of mRNA vaccines was established during the COVID-19 pandemic. Now, a new wave of candidates could soon hit the market for cancer, influenza and more.
September 16, 2024
·
5 min read
·
Ben Hargreaves
RSV
Pfizer Wins FDA Approval of RSV Vaccine for Broader Adult Population
Pfizer’s Abrysvo is the first respiratory syncytial virus vaccine that can be used for adults less than 50 years of age. Tuesday’s label expansion covers younger adults who are deemed at higher risk of RSV-related lower respiratory tract disease.
October 23, 2024
·
2 min read
·
Tristan Manalac
FDA
Novavax Shares Slide as FDA Pauses COVID/Flu Vaccine Candidates
The clinical hold affects Novavax’s COVID-flu combo and standalone flu vaccines, which were on the cusp of Phase III testing. The FDA’s decision stems from a report of a serious adverse event of motor neuropathy, Novavax said.
October 16, 2024
·
1 min read
·
Annalee Armstrong
Rational’s Experimental Herpes Vaccine Shows Preclinical Promise
Rational Vaccines said findings from a pilot study showed that RVX201 led to a reduction in recurrent genital lesions when compared to gD2-alum/MPL vaccine in animal studies.
July 8, 2022
·
2 min read
·
Alex Keown
Legal
GSK Settles Zantac Lawsuits for $2.2B, Analysts Now Shift Focus to Vaccines
The settlement, which is at the low end of Jefferies analysts’ $2 billion to $3.5 billion estimate, will resolve 93% of the product liability cases regarding allegations that GSK’s heartburn drug could cause cancer. Analysts say separate concerns remain about its vaccines business.
October 10, 2024
·
2 min read
·
Tristan Manalac
News
Curevo Vaccine Presents Amezosvatein Shingles Vaccine Data at ID Week
October 16, 2024
·
9 min read
1 of 6,569
Next
